Current position:Home >Product >
2H-Indol-2-one, 3-[1,3-dihydro-3-(hydroxyimino)-2H-indol-2-ylidene]-1,3-dihydro-1-meth yl-
2H-Indol-2-one, 3-[1,3-dihydro-3-(hydroxyimino)-2H-indol-2-ylidene]-1,3-dihydro-1-meth yl-(160807-50-1)
- Name: 2H-Indol-2-one, 3-[1,3-dihydro-3-(hydroxyimino)-2H-indol-2-ylidene]-1,3-dihydro-1-meth yl-
- Synonyms:
- Molecular Formula:C17H13N3O2
- Molecular Weight:
- CAS Registry Number:160807-50-1
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.160807-50-1 2H-Indol-2-one, 3-[1,3-dihydro-3-(hydroxyimino)-2H-indol-2-ylidene]-1,3-dihydro-1-meth yl-
Assay:99% Appearance:White powder Package:25KGS/Drum Storage:Room temperature Transportation:BY SEA Application:API锛孭harmaceutical intermediates
Min. Order:1Gram
Supplier:HENAN NEW BLUE CHEMICAL CO.,LTD [
China (Mainland)] CAS No.160807-50-1 2H-Indol-2-one, 3-[1,3-dihydro-3-(hydroxyimino)-2H-indol-2-ylidene]-1,3-dihydro-1-meth yl-
Assay:99.90% Appearance:solid or liquid Package:Foil bag; Drum; Plastic bottle Storage:in sealed air resistant place Transportation:by sea or air Application:Pharma;Industry;Agricultural
Min. Order:0
Supplier:Kono Chem Co.,Ltd [
China (Mainland)]
Other Product
- 160800-58-8/1-Pyrrolidinecarboxylic acid, 2-[(1R,2R)-3-[[2-(3,4-dimethoxyphenyl)ethyl]amino]-1-methoxy-2-methyl -3-oxopropyl]-, 1,1-dimethylethyl ester, (2S)-
- 160800-60-2/1-Pyrrolidinecarboxylic acid, 2-[(1R,2R)-3-[[2-(4-chlorophenyl)ethyl]amino]-1-methoxy-2-methyl-3-oxo propyl]-, 1,1-dimethylethyl ester, (2S)-
- 160800-61-3/1-Pyrrolidinecarboxylic acid, 2-[(1R,2R)-3-[[2-(4-fluorophenyl)ethyl]amino]-1-methoxy-2-methyl-3-oxo propyl]-, 1,1-dimethylethyl ester, (2S)-
- 160800-62-4/1-Pyrrolidinecarboxylic acid, 2-[(1R,2R)-3-[[2-(3-chlorophenyl)ethyl]amino]-1-methoxy-2-methyl-3-oxo propyl]-, 1,1-dimethylethyl ester, (2S)-
- 160800-63-5/1-Pyrrolidinecarboxylic acid, 2-[(1R,2R)-3-[[2-(2-chlorophenyl)ethyl]amino]-1-methoxy-2-methyl-3-oxo propyl]-, 1,1-dimethylethyl ester, (2S)-
- 160800-64-6/1-Pyrrolidinecarboxylic acid, 2-[(1R,2R)-3-[[(1R,2R)-2-hydroxy-1-methyl-2-phenylethyl]methylamino]- 1-methoxy-2-methyl-3-oxopropyl]-, 1,1-dimethylethyl ester, (2S)-
- 160802-60-8/Benzenepropanamide, a-amino-N-heptyl-, (S)-
- 160802-78-8/D-Phenylalaninamide, D-arginyl-N-[12-[(N-D-arginyl-D-phenylalanyl)amino]dodecyl]-
- 160802-83-5/Benzenepropanamide, a-[(aminoiminomethyl)amino]-N-heptyl-, (S)-
- 160802-85-7/Benzenepropanamide, a-[(aminoiminomethyl)amino]-N-dodecyl-, (S)-
- 160802-87-9/Benzenepropanamide, a-[(aminoiminomethyl)amino]-N-tetradecyl-, (S)-
- 160802-88-0/Benzenepropanamide, a-[(aminoiminomethyl)amino]-N-hexadecyl-, (S)-
- 160802-89-1/L-Phenylalaninamide, L-arginyl-N,N-dioctyl-
- 160803-15-6/2-Hexenoic acid, 4-(acetyloxy)-5-[[(1,1-dimethylethoxy)carbonyl]amino]-6-phenyl-, 1,1-dimethylethyl ester, (2E,4S,5S)-
- 160803-18-9/1H-Indene-1-acetic acid, 2,3-dihydro-1-hydroxy-3,6-dimethyl-, ethyl ester
- 160806-07-5/1,4,7,10-Tetraazabicyclo[5.5.2]tetradecane, 4,10-dimethyl-
- 160806-17-7/1,2-Pyrrolidinedicarboxylic acid, 5-oxo-4-[2-oxo-2-(phenylmethoxy)ethyl]-, bis(1,1-dimethylethyl) ester, (2S,4S)-
- 1608-06-6/Furan, 2-(1-buten-3-ynyl)-, (Z)-
- 16080-74-3/Cyclohexanone, 2,6-dibromo-, trans-
- 160807-50-1/2H-Indol-2-one, 3-[1,3-dihydro-3-(hydroxyimino)-2H-indol-2-ylidene]-1,3-dihydro-1-meth yl-
- 16080-75-4/Cyclohexanone, 2,6-dibromo-, cis-
- 160808-60-6/2-Propenoic acid, 2-methyl-, (5-ethyl-2-oxo-1,3-dioxan-5-yl)methyl ester
- 160808-62-8/Butanoic acid, 3-[(aminocarbonyl)hydrazono]-, ethyl ester, (3Z)-
- 160809-30-3/Benzamide, N-[2-(3,4-dichlorophenyl)-4-oxobutyl]-N-methyl-
- 160809-39-2/1-Piperidinecarboxylic acid, 4-(1-hydroxy-1-methylethyl)-, phenylmethyl ester
- 160810-14-0/Benzene, 1,2,3-trifluoro-5-[[2-fluoro-4-(4-propylcyclohexyl)phenyl]ethynyl]-, trans-
- 160811-51-8/Anthracene, 1,8-difluoro-9-(1-methyl-2-propenyl)-
- 160815-40-7/1H-Imidazole-1-sulfonamide, 5-[8-(1,3-dihydro-1,3-dioxo-2H-isoindol-2-yl)octyl]-N,N-dimethyl-
- 160815-42-9/1H-Imidazole-1-sulfonamide, 5-(6-aminohexyl)-N,N-dimethyl-
- 160815-43-0/1H-Imidazole-1-sulfonamide, 5-(8-aminooctyl)-N,N-dimethyl-